Characteristics of patients and transplants
A total of 6551 AML patients who underwent allogenic HSCT with MAC regimens were extracted from the Japanese nationwide registry. Among them, 905 patients received FLU/BU4, while 5646 patients received…
Improved post-transplant outcomes for elderly acute myeloid leukemia patients conditioned with FLU/BU4 rather than conventional MAC regimens
